Expression and functional characteristics of tubular transporters: P-glycoprotein, PEPT1, and PEPT2 in renal mass reduction and diabetes.
Renal mass reduction is associated with a compromise in renal excretion, and thus dosages of drugs need to be adjusted to avoid adverse reactions and to ensure their effectiveness. A prototypic example is patients who had undergone transplantation due to a variety of causes, including diabetic nephropathy; the latter appears to be the major cause of renal failure requiring hemodialysis and transplantation. Conceivably, hyperglycemia with reduced renal mass interferes in the delivery of xenobiotics handled by various tubular transporters. In this investigation, effect of renal mass reduction/hyperglycemia on gene and protein expression of P-glycoprotein (Pgp), PEPT1, and PEPT2 was assessed. Also, [H(3)]glycylsarcosine uptake, a prototype of dipeptide, was measured in various groups of rats: sham-operated, uninephrectomized, streptozotocin-induced diabetes, and diabetic + uninephrectomized. An increase in Pgp, PEPT1, and PEPT2 expression was observed in kidneys of uninephrectomy rats, the highest being in the Pgp. Similarly, an increase was observed in diabetic rats who had undergone uninephrectomy, although less than those with nephrectomy alone. No differences were observed between sham-operated and diabetic groups. Increased uptake of [H(3)]glycylsarcosine was also seen in uninephrectomised rats. A modest uptake was observed in diabetic rats who had undergone uninephrectomy. The data suggest that uninephrectomy induces an increase in the expression and activity of transporters localized to renal tubular epithelial brush border. The fact that upregulation and activity of the peptide transporters were less in kidneys of diabetic animals who had undergone uninephrectomy compared with uninephrectomy alone suggests that hyperglycemia interferes in their expression and activity during the compensatory phase.
Tramonti
Gianfranco
G
Dept. of Pathology, Northwestern Univ. Medical School, 303 E. Chicago Ave, Chicago, IL, USA.
Xie
Ping
P
Wallner
Elisabeth I
EI
Danesh
Farhad R
FR
Kanwar
Yashpal S
YS
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D003928:Diabetic Nephropathies / Q000378:metabolism* / Q000503:physiopathology*; D004151:Dipeptides / Q000493:pharmacokinetics; D005260:Female; D015870:Gene Expression / Q000502:physiology; D006943:Hyperglycemia / Q000378:metabolism / Q000503:physiopathology; D017403:In Situ Hybridization; D007684:Kidney Tubules / Q000378:metabolism; D008871:Microvilli / Q000378:metabolism; D009392:Nephrectomy; D000074011:Peptide Transporter 1; D016133:Polymerase Chain Reaction / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D027981:Symporters / Q000235:genetics* / Q000378:metabolism; D014316:Tritium
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D004151:Dipeptides; D000074011:Peptide Transporter 1; C489940:Slc15a1 protein, rat; D027981:Symporters; C093694:hydrogen-coupled oligopeptide transporter PepT2; D014316:Tritium; C004194:glycylsarcosine